Pluristem Therapeutics Inc (PSTI)

[Scott999]

Hey Blue. Respectfully, I'm not too sure on your assessment of Cleveland Biolabs. Sure if something was to happen, they would be using their product, as it is available. In what quantities, I have no idea. But that is why PLX should be a top priority for them as well. To have another product on their shelves would be an incredible asset to have.

But something seems fishy about their study on ARS. It was discussed in depth a little while ago. Just something about it didn't seem right. And being involved with Russia just seems to add to my doubt.

They are sitting at a $35 million market cap. So I would think the street doesn't believe anything is imminent. But if you got some coin there as well, your odds of one of them getting a stockpiling contract is greater.

There are others in this space, and we are not alone. The need to have some product(s) available is obviously an understatement. I do believe that we are one of the top, if not THE top, product candidates to fill this void. Filgrastim, with all its blood transfusions and other measures that go along with it, seems unlikely to be desired if mass casualties were to happen.

But you sure hit the nail on the head. Competition is abound everywhere in the pharmaceutical industry. Many with incredibly deep pockets to back small biotechs to diversify their drugs and drug candidates. The longer the delays, the more likely others will be first to market.

This ARS pivotal trial is so important both financially and to give credence to their products. Hit a home run with this one, and so many offers will come in for their others, even a backseat driving, Joe Schmo like me could make a deal.